BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 24169548)

  • 1. β-Arrestin 1 and 2 and G protein-coupled receptor kinase 2 expression in pituitary adenomas: role in the regulation of response to somatostatin analogue treatment in patients with acromegaly.
    Gatto F; Feelders R; van der Pas R; Kros JM; Dogan F; van Koetsveld PM; van der Lelij AJ; Neggers SJ; Minuto F; de Herder W; Lamberts SW; Ferone D; Hofland LJ
    Endocrinology; 2013 Dec; 154(12):4715-25. PubMed ID: 24169548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low beta-arrestin expression correlates with the responsiveness to long-term somatostatin analog treatment in acromegaly.
    Gatto F; Biermasz NR; Feelders RA; Kros JM; Dogan F; van der Lely AJ; Neggers SJ; Lamberts SW; Pereira AM; Ferone D; Hofland LJ
    Eur J Endocrinol; 2016 May; 174(5):651-62. PubMed ID: 26888629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and function of somatostatin receptor subtype 1 in human growth hormone secreting pituitary tumors deriving from patients partially responsive or resistant to long-term treatment with somatostatin analogs.
    Matrone C; Pivonello R; Colao A; Cappabianca P; Cavallo LM; Del Basso De Caro ML; Taylor JE; Culler MD; Lombardi G; Di Renzo GF; Annunziato L
    Neuroendocrinology; 2004 Mar; 79(3):142-8. PubMed ID: 15103227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro Head-to-Head Comparison Between Octreotide and Pasireotide in GH-Secreting Pituitary Adenomas.
    Gatto F; Feelders RA; Franck SE; van Koetsveld PM; Dogan F; Kros JM; Neggers SJCMM; van der Lely AJ; Lamberts SWJ; Ferone D; Hofland LJ
    J Clin Endocrinol Metab; 2017 Jun; 102(6):2009-2018. PubMed ID: 28323931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia/ischemia modulates G protein-coupled receptor kinase 2 and beta-arrestin-1 levels in the neonatal rat brain.
    Lombardi MS; van den Tweel E; Kavelaars A; Groenendaal F; van Bel F; Heijnen CJ
    Stroke; 2004 Apr; 35(4):981-6. PubMed ID: 15017017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial distribution and regulation of GRK and beta-arrestin isoforms in congestive heart failure in rats.
    Vinge LE; Øie E; Andersson Y; Grøgaard HK; Andersen G; Attramadal H
    Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2490-9. PubMed ID: 11709416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tonic inhibition by G protein-coupled receptor kinase 2 of Akt/endothelial nitric-oxide synthase signaling in human vascular endothelial cells under conditions of hyperglycemia with high insulin levels.
    Taguchi K; Sakata K; Ohashi W; Imaizumi T; Imura J; Hattori Y
    J Pharmacol Exp Ther; 2014 May; 349(2):199-208. PubMed ID: 24570070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pasireotide and octreotide stimulate distinct patterns of sst2A somatostatin receptor phosphorylation.
    Pöll F; Lehmann D; Illing S; Ginj M; Jacobs S; Lupp A; Stumm R; Schulz S
    Mol Endocrinol; 2010 Feb; 24(2):436-46. PubMed ID: 20051480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression analysis of dopamine receptor subtypes in normal human pituitaries, nonfunctioning pituitary adenomas and somatotropinomas, and the association between dopamine and somatostatin receptors with clinical response to octreotide-LAR in acromegaly.
    Neto LV; Machado Ede O; Luque RM; Taboada GF; Marcondes JB; Chimelli LM; Quintella LP; Niemeyer P; de Carvalho DP; Kineman RD; Gadelha MR
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1931-7. PubMed ID: 19293270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential regulatory roles for G protein-coupled receptor kinases and beta-arrestins in gonadotropin-releasing hormone receptor signaling.
    Neill JD; Duck LW; Musgrove LC; Sellers JC
    Endocrinology; 1998 Apr; 139(4):1781-8. PubMed ID: 9528962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does GRK-β arrestin machinery work as a "switch on" for GPR17-mediated activation of intracellular signaling pathways?
    Daniele S; Trincavelli ML; Fumagalli M; Zappelli E; Lecca D; Bonfanti E; Campiglia P; Abbracchio MP; Martini C
    Cell Signal; 2014 Jun; 26(6):1310-25. PubMed ID: 24613411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human somatostatin receptor subtypes in acromegaly: distinct patterns of messenger ribonucleic acid expression and hormone suppression identify different tumoral phenotypes.
    Jaquet P; Saveanu A; Gunz G; Fina F; Zamora AJ; Grino M; Culler MD; Moreau JP; Enjalbert A; Ouafik LH
    J Clin Endocrinol Metab; 2000 Feb; 85(2):781-92. PubMed ID: 10690891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors.
    Shimon I; Yan X; Taylor JE; Weiss MH; Culler MD; Melmed S
    J Clin Invest; 1997 Nov; 100(9):2386-92. PubMed ID: 9410919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of acromegaly in the era of personalized and predictive medicine.
    Puig Domingo M
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):3-14. PubMed ID: 25640882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of GPR54 signaling by GRK2 and {beta}-arrestin.
    Pampillo M; Camuso N; Taylor JE; Szereszewski JM; Ahow MR; Zajac M; Millar RP; Bhattacharya M; Babwah AV
    Mol Endocrinol; 2009 Dec; 23(12):2060-74. PubMed ID: 19846537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression patterns of the regulatory proteins G protein-coupled receptor kinase 2 and beta-arrestin 1 during rat postnatal brain development: effect of hypothyroidism.
    Penela P; Alvarez-Dolado M; Muñoz A; Mayor F
    Eur J Biochem; 2000 Jul; 267(14):4390-6. PubMed ID: 10880962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of β
    Nash CA; Nelson CP; Mistry R; Moeller-Olsen C; Christofidou E; Challiss RAJ; Willets JM
    Cell Signal; 2018 Nov; 51():86-98. PubMed ID: 30075183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of somatostatin receptors on human pituitary adenomas in vivo and ex vivo.
    Nielsen S; Mellemkjaer S; Rasmussen LM; Ledet T; Olsen N; Bojsen-Møller M; Astrup J; Weeke J; Jørgensen JO
    J Endocrinol Invest; 2001 Jun; 24(6):430-7. PubMed ID: 11434667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of somatostatin receptor subtypes in human pituitary adenomas -- immunohistochemical studies.
    Pisarek H; Pawlikowski M; Kunert-Radek J; Radek M
    Endokrynol Pol; 2009; 60(4):240-51. PubMed ID: 19753537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple scaffolding functions of {beta}-arrestins in the degradation of G protein-coupled receptor kinase 2.
    Nogués L; Salcedo A; Mayor F; Penela P
    J Biol Chem; 2011 Jan; 286(2):1165-73. PubMed ID: 21081496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.